(1R,4R)-6-FLUORO-(N-METHYL- OR N,N-DIMETHYL-)-4-PHENYL-4,9-DIH YDRO-3H-SPIRO-[CYCLOHEXANE-1,1-PYRANO[3,4,B]INDOL]-4-AMINE FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME.
The invention relates to a pharmaceutical dosage form comprising (1r,4r)-6-Fluoro-(N- methyl- or N,N-dimethyl-)-4-phenyl-4,9-dihydro-3H-spiro-[cyclohexane-1, 1-pyrano[3,4,b]- indol]-4-amine or a physiologically acceptable salt thereof, for use in the treatment of fibromyalgia or chronic fatigue syndrome.La invención se refiere a una forma de dosificación farmacéutica que comprende (1r,4r)-6´-fluoro-(N-metil- ó N,N-dimetil-)-4-fenil- 4´,9´-dihidro-3´H-espiro-[ciclohexano-1,1´-pirano-[3,4,b]indol]-4 -amina o una sal fisiológicamente aceptable del mismo, para usarse en el tratamiento de fibromialgia o síndrome de fatiga crónica.